ChEMBL ligand: CHEMBL870 (Alendronate, Alendronic Acid, Fosamax, Binosto)
farnesyl diphosphate synthase/Farnesyl diphosphate synthase in Human [ChEMBL: CHEMBL1782] [GtoPdb: 644] [UniProtKB: P14324] 1 CHEMBL870_lig_chart_1 Farnesyl diphosphate synthase Human There should be some charts here, you may need to enable JavaScript!
Farnesyl pyrophosphate synthase in Leishmania donovani [ChEMBL: CHEMBL3693] [UniProtKB: Q0GKD7] This target only has 1 pki data point 2 CHEMBL870_lig_chart_2 Farnesyl pyrophosphate synthase Leishmania donovani There should be some charts here, you may need to enable JavaScript!

DB	Assay description	Assay Type	Standard value	Standard parameter	Original value	Original units	Original parameter	Reference
farnesyl diphosphate synthase/Farnesyl diphosphate synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1782] [GtoPdb: 644] [UniProtKB: P14324]
ChEMBL	Inhibition of human recombinant FPPS expressed in Escherichia coli BL21	B	6.41	pKi	393.1	nM	Ki	J. Med. Chem. (2008) 51: 2187-2195 [PMID:18327899]
ChEMBL	Binding affinity towards farnesyl Pyrophosphate Synthase using [14C]- isopentenyl pyrophosphate as radioligand	B	7.04	pKi	91	nM	Ki	J. Med. Chem. (2003) 46: 5171-5183 [PMID:14613320]
ChEMBL	Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins	B	7.35	pKi	44.2	nM	Ki	J. Med. Chem. (2008) 51: 2187-2195 [PMID:18327899]
ChEMBL	Inhibition of human recombinant FPPS expressed in Escherichia coli BL21	B	5.65	pIC50	2249	nM	IC50	J. Med. Chem. (2008) 51: 2187-2195 [PMID:18327899]
ChEMBL	Inhibitory activity against farnesyl Pyrophosphate Synthase expressed as #NAME? (M)	B	6.02	pIC50	954.99	nM	IC50	J. Med. Chem. (2003) 46: 5171-5183 [PMID:14613320]
ChEMBL	Inhibitory activity against farnesyl Pyrophosphate Synthase was determined	B	6.02	pIC50	950	nM	IC50	J. Med. Chem. (2003) 46: 5171-5183 [PMID:14613320]
GtoPdb	-	-	6.34	pIC50	460	nM	IC50	Arch. Biochem. Biophys. (2000) 373: 231-41 [PMID:10620343]
ChEMBL	Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins	B	6.59	pIC50	260	nM	IC50	J. Med. Chem. (2008) 51: 2187-2195 [PMID:18327899]
GtoPdb	In vitro inhibition of recombinant human protein expressed in E coli.	-	7.3	pIC50	50	nM	IC50	J. Pharmacol. Exp. Ther. (2001) 296: 235-42 [PMID:11160603]
ChEMBL	Inhibitory activity against the human recombinant FPPSase (Farnesyl diphosphate) enzyme	B	7.3	pIC50	50	nM	IC50	J. Med. Chem. (2002) 45: 2185-2196 [PMID:12014956]
ChEMBL	Inhibition of recombinant human FPPS expressed in Escherichia coli by scintillation counting	B	7.3	pIC50	50	nM	IC50	J. Med. Chem. (2011) 54: 5955-5980 [PMID:21780776]
Farnesyl pyrophosphate synthase in Leishmania donovani (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3693] [UniProtKB: Q0GKD7]
ChEMBL	Binding affinity towards Farnesyl diphosphate synthase from leishmania major	B	7.02	pKi	95	nM	Ki	J. Med. Chem. (2005) 48: 2957-2963 [PMID:15828834]

ChEMBL data shown on this page come from version 27:

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibrián-Uhalte E, Davies M, Dedman N, Karlsson A, Magariños MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]